Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079726705> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2079726705 endingPage "219" @default.
- W2079726705 startingPage "176" @default.
- W2079726705 abstract "[t]he great problem for medical research … is the chasm between the society's general interest in medical progress and the individual interest of the patient involved. Resolving these two conflicting interests is the task of the law.1 Research involving humans raises many ethical and legal issues, and its regulation essentially involves balancing the interests of the health professional/researcher conducting the trial, with those of medical science and progress generally, and the welfare of the humans who participate in it. While much has been written about the regulation of research, in this article I explore an under-considered aspect of the area—the selection of participants. The importance of clinical trials, participant selection and ‘informed consent’ was dramatically highlighted by the Phase 1 clinical trials of TGN1412, held in London in March 2006.2 TGN1412 is a monoclonal antibody, a genetically engineered protein that is part mouse and part human, designed to suppress an immune system reaction. It was developed to treat immunological diseases, including multiple sclerosis, some cancers and rheumatoid arthritis, and had previously been tested on non-human animals. On the first day of the Medicines and Healthcare products Regulatory Agency (MHRA)-approved clinical trial, six healthy volunteers required intensive care following allegedly hitherto unexpected side effects, including breathing difficulties and extreme inflammation in their tissues and organs. Despite extensive media coverage of the trial and outrage at the side effects thereby experienced, inquiries from people wanting to be involved in other clinical trials have apparently increased.3 Thus, far from deterring potential participants, the risks of side effects appear to be outweighed by the ability to help others and the financial benefit, £2,000 in the TGN1412 trial, which can accrue from involvement in trials. The selection of trial participants thus remains a relevant and important area of study." @default.
- W2079726705 created "2016-06-24" @default.
- W2079726705 creator A5042244822 @default.
- W2079726705 date "2007-05-18" @default.
- W2079726705 modified "2023-09-23" @default.
- W2079726705 title "'OH PICK ME, PICK ME'--SELECTING PARTICIPANTS FOR XENOTRANSPLANT CLINICAL TRIALS" @default.
- W2079726705 doi "https://doi.org/10.1093/medlaw/fwm005" @default.
- W2079726705 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17513832" @default.
- W2079726705 hasPublicationYear "2007" @default.
- W2079726705 type Work @default.
- W2079726705 sameAs 2079726705 @default.
- W2079726705 citedByCount "3" @default.
- W2079726705 countsByYear W20797267052014 @default.
- W2079726705 countsByYear W20797267052021 @default.
- W2079726705 crossrefType "journal-article" @default.
- W2079726705 hasAuthorship W2079726705A5042244822 @default.
- W2079726705 hasConcept C108170787 @default.
- W2079726705 hasConcept C111472728 @default.
- W2079726705 hasConcept C138885662 @default.
- W2079726705 hasConcept C142724271 @default.
- W2079726705 hasConcept C160735492 @default.
- W2079726705 hasConcept C17744445 @default.
- W2079726705 hasConcept C188084074 @default.
- W2079726705 hasConcept C199539241 @default.
- W2079726705 hasConcept C204787440 @default.
- W2079726705 hasConcept C535046627 @default.
- W2079726705 hasConcept C68122502 @default.
- W2079726705 hasConcept C71924100 @default.
- W2079726705 hasConceptScore W2079726705C108170787 @default.
- W2079726705 hasConceptScore W2079726705C111472728 @default.
- W2079726705 hasConceptScore W2079726705C138885662 @default.
- W2079726705 hasConceptScore W2079726705C142724271 @default.
- W2079726705 hasConceptScore W2079726705C160735492 @default.
- W2079726705 hasConceptScore W2079726705C17744445 @default.
- W2079726705 hasConceptScore W2079726705C188084074 @default.
- W2079726705 hasConceptScore W2079726705C199539241 @default.
- W2079726705 hasConceptScore W2079726705C204787440 @default.
- W2079726705 hasConceptScore W2079726705C535046627 @default.
- W2079726705 hasConceptScore W2079726705C68122502 @default.
- W2079726705 hasConceptScore W2079726705C71924100 @default.
- W2079726705 hasIssue "2" @default.
- W2079726705 hasLocation W20797267051 @default.
- W2079726705 hasLocation W20797267052 @default.
- W2079726705 hasOpenAccess W2079726705 @default.
- W2079726705 hasPrimaryLocation W20797267051 @default.
- W2079726705 hasRelatedWork W189803326 @default.
- W2079726705 hasRelatedWork W194563242 @default.
- W2079726705 hasRelatedWork W1978566957 @default.
- W2079726705 hasRelatedWork W2137636999 @default.
- W2079726705 hasRelatedWork W2202399480 @default.
- W2079726705 hasRelatedWork W2356327458 @default.
- W2079726705 hasRelatedWork W2944943140 @default.
- W2079726705 hasRelatedWork W3184643344 @default.
- W2079726705 hasRelatedWork W2123280163 @default.
- W2079726705 hasRelatedWork W2633433752 @default.
- W2079726705 hasVolume "15" @default.
- W2079726705 isParatext "false" @default.
- W2079726705 isRetracted "false" @default.
- W2079726705 magId "2079726705" @default.
- W2079726705 workType "article" @default.